Masatomi Iijima Selected Research

1- naphthylacetyl- (O- methyl)- tyrosyl- valyl- (O- methyl)- tyrosinal (TP 110)

1/2010	Increased ABCB1 expression in TP-110-resistant RPMI-8226 cells.
4/2009	TP-110, a new proteasome inhibitor, down-regulates IAPs in human multiple myeloma cells.
4/2007	A new proteasome inhibitor, TP-110, induces apoptosis in human prostate cancer PC-3 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masatomi Iijima Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 04/2007
2	Multiple Myeloma 01/2010 - 04/2009
1	Toxoplasmosis 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Leukemia 04/2009
1	Prostatic Neoplasms (Prostate Cancer) 04/2007

Drug/Important Bio-Agent (IBA)

3	Proteasome InhibitorsIBA 01/2010 - 04/2007
3	1- naphthylacetyl- (O- methyl)- tyrosyl- valyl- (O- methyl)- tyrosinal (TP 110)IBA 01/2010 - 04/2007
2	Biological ProductsIBA 01/2022 - 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2020
1	metacytofilinIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	leucinostatin YIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Phosphotransferases (Kinase)IBA 09/2017
1	AnthraquinonesIBA 02/2015
1	Apoptosis Regulatory ProteinsIBA 04/2009
1	tyropeptin AIBA 04/2007

Therapy/Procedure

1	Therapeutics 01/2022